Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
Journal of Biomolecular Screening
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
1087057105277234v1
1087057105277234v2
10/6/573    most recent
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (7)
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Benson, N.
Right arrow Articles by Winkler, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Benson, N.
Right arrow Articles by Winkler, D.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

NanoStore: A Concept for Logistical Improvements of Compound Handling in High-Throughput Screening

Neil Benson

Discovery Biology, Pfizer Global Research and Development, Ramsgate Road, Sandwich, CT13 9NJ, United Kingdom

Helen F. Boyd

Discovery Biology, Pfizer Global Research and Development, Ramsgate Road, Sandwich, CT13 9NJ, United Kingdom

Jeremy R. Everett

Medicinal Technologies, Pfizer Global Research and Development, Ramsgate Road, Sandwich, CT13 9NJ, United Kingdom

Joachim Fries

Drug Discovery Services, Evotec OAI, Hamburg, FRG

Philip Gribbon

Medicinal Technologies, Pfizer Global Research and Development, Ramsgate Road, Sandwich, CT13 9NJ, United Kingdom

Nuzrul Haque

Discovery Biology, Pfizer Global Research and Development, Ramsgate Road, Sandwich, CT13 9NJ, United Kingdom

Karsten Henco

Drug Discovery Services, Evotec OAI, Hamburg, FRG

Timm Jessen

Drug Discovery Services, Evotec OAI, Hamburg, FRG

William H. Martin

Exploratory Medicinal Sciences, Pfizer Global Research and Development, Eastern Point Road, Groton, CT 06340

Travis J. Mathewson

Exploratory Medicinal Sciences, Pfizer Global Research and Development, Eastern Point Road, Groton, CT 06340

R. Eryl Sharp

Exploratory Medicinal Sciences, Pfizer Global Research and Development, Eastern Point Road, Groton, CT 06340

Robin W. Spencer

Exploratory Medicinal Sciences, Pfizer Global Research and Development, Eastern Point Road, Groton, CT 06340

Frank Stuhmeier

Discovery Biology, Pfizer Global Research and Development, Ramsgate Road, Sandwich, CT13 9NJ, United Kingdom

Mark S. Wallace

Exploratory Medicinal Sciences, Pfizer Global Research and Development, Eastern Point Road, Groton, CT 06340

Dirk Winkler

Drug Discovery Services, Evotec OAI, Hamburg, FRG

Small molecule screening, the systematic encounter of biology space with chemical space, has provoked the emergence of a whole industry that recreates itself by constant iterative improvements to this process. The authors describe an approach to tackle the problem for one of the most time-consuming steps in the execution of a screening campaign, namely, the reformatting of high-throughput screening test compounds from master plates to daughter assay plates used in the execution of the screen. Through an engineered storage procedure, they prepare plates ahead of the screening process with the respective compounds in a ready-to-use format. They show the biological inertness of the method and how it facilitates efficient recovery of compound activity. This uncoupling of normally interconnected processes provides time and compound savings, avoids repeated freeze-thaw cycles of compound solutions, and removes the problems associated with the DMSO sensitivity of certain assays types.

Key Words: assay miniaturization • ultra-high-throughput screening • compound storage and recovery • 1536-well and 2080-well NanoCarriersTM

This version was published on September 1, 2005

Journal of Biomolecular Screening, Vol. 10, No. 6, 573-580 (2005)
DOI: 10.1177/1087057105277234


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
J Biomol ScreenHome page
H. Eriksson, J. Brengdahl, P. Sandstrom, M. Rohman, and B. Becker
Validation of Low-Volume 1536-Well Assay-Ready Compound Plates
J Biomol Screen, June 1, 2009; 14(5): 468 - 475.
[Abstract] [PDF]


Home page
J Biomol ScreenHome page
W. P. Janzen and I. G. Popa-Burke
Review: Advances in Improving the Quality and Flexibility of Compound Management
J Biomol Screen, June 1, 2009; 14(5): 444 - 451.
[Abstract] [PDF]


Home page
J Biomol ScreenHome page
P. W. Woodward, C. Williams, A. Sewing, and N. Benson
Improving the Design and Analysis of High-Throughput Screening Technology Comparison Experiments Using Statistical Modeling
J Biomol Screen, February 1, 2006; 11(1): 5 - 12.
[Abstract] [PDF]